Valuation: Clover Corporation Limited

Market Cap 159M 113M 97.4M 90.96M 83.44M 157M 10.72B 1.07B 419M 5.37B 423M 414M 17.76B P/E 2026 *
16.4x
P/E 2027 * 11.9x
Enterprise Value 157M 111M 95.99M 89.64M 82.24M 155M 10.56B 1.05B 413M 5.29B 417M 408M 17.5B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.31x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+2.08%
1 week+4.26%
Current month+2.08%
1 month+29.80%
3 months+2.89%
6 months+27.27%
Current year+24.05%
1 week 0.93
Extreme 0.93
0.99
1 month 0.76
Extreme 0.76
0.99
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
06/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+2.08%+4.26%+73.45%-9.26% 113M
+0.46%+1.93%+34.94%+86.41% 13.92B
+2.95%+8.31%-19.25%+298.52% 8.5B
-0.10%-3.35%-15.35%-51.09% 2.5B
+9.59%+9.99%+21.31%+71.95% 1.35B
+7.78%+5.72%-22.08%-22.25% 1.35B
-4.54%-6.70%-70.35%-68.74% 1.34B
+7.30%-0.56%+38.76%-30.93% 1.29B
-3.33%+4.55%-34.07% - 1.17B
-0.63%+9.04%-62.31%-70.19% 982M
Average +2.16%+3.18%-5.50%+22.71% 3.25B
Weighted average by Cap. +1.65%+4.21%+4.49%+110.86%

Financials

2026 *2027 *
Net sales 94M 66.39M 57.43M 53.63M 49.2M 92.53M 6.32B 629M 247M 3.17B 249M 244M 10.47B 116M 82M 70.93M 66.24M 60.76M 114M 7.8B 777M 305M 3.91B 308M 301M 12.93B
Net income 9.8M 6.92M 5.99M 5.59M 5.13M 9.65M 659M 65.6M 25.75M 330M 25.99M 25.42M 1.09B 13.5M 9.53M 8.25M 7.7M 7.07M 13.29M 907M 90.36M 35.47M 455M 35.8M 35.02M 1.5B
Net Debt -2.3M -1.62M -1.41M -1.31M -1.2M -2.26M -155M -15.39M -6.04M -77.49M -6.1M -5.97M -256M -7.2M -5.09M -4.4M -4.11M -3.77M -7.09M -484M -48.19M -18.92M -243M -19.1M -18.68M -802M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
10/08/26 A$0.9800 +2.08% 113,464
07/08/26 A$0.9600 0.00% 10,011
06/08/26 A$0.9600 0.00% 24,381
05/08/26 A$0.9600 +2.13% 9,072
04/08/26 A$0.9400 0.00% 2,049
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9600AUD
Average target price
1.280AUD
Spread / Average Target
+33.33%

Annual profits - Rate of surprise